SEVERE COURSE OF CUTANEOUS MELANOMA-ASSOCIATED PARANEOPLASTIC RETINOPATHY

被引:61
作者
KELLNER, U [1 ]
BORNFELD, N [1 ]
FOERSTER, MH [1 ]
机构
[1] FREE UNIV BERLIN,UNIV BENJAMIN FRANKLIN,POLIKLIN,D-12200 BERLIN,GERMANY
关键词
D O I
10.1136/bjo.79.8.746
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background-Melanoma associated retinopathy (MAR) is a paraneoplastic syndrome in metastatic cutaneous melanoma presenting with nightblindness, light sensations, mild visual loss, and reduced b-waves in the electroretinogram (ERG). Methods-A patient with MAR was followed for a period of 25 months with repeated examinations including visual field testing and recording of standard electro-oculography, standard ERG, and photopic On and Off responses. Results-A male patient with a very severe course of MAR is described. In addition to the clinical signs seen in previous patients, severe visual deterioration and vitreous inflammation were the predominant signs. The vitreous inflammation resolved after systemic corticosteroid therapy. Nightblindness and the reduced b-waves in the ERG remained unchanged during the follow up period. However, further visual deterioration and paracentral scotomas developed. Dark adaptation was markedly abnormal. Photopic On responses were reduced, but Off responses were preserved. Antibodies against retinal bipolar cells were isolated from blood samples of this patient. Conclusion-Vitreous inflammation may mask the diagnosis of MAR. ERG findings indicate that the more severe and progressive course is the result of local retinal changes and not progressive generalised retinal degeneration.
引用
收藏
页码:746 / 752
页数:7
相关论文
共 44 条
[1]  
Sawyer R.A., Selhorts J.B., Zimmerman L.E., Blindness caused by photoreceptor degeneration as a remote effect of cancer, AmJOphthalmol, 81, (1976)
[2]  
Jacobson D.M., Thirkill C.E., Tipping S.J., A clinical triad to diagnose paraneoplastic retinopathy, Ann Neurol, 28, (1990)
[3]  
Keltner J.L., Rith A.M., Chang S., Photoreceptor degeneration. Possible autoimmune disorder, Arch Ophthalmol, 101, (1983)
[4]  
Keltner J.E., Thirkill C.E., Tyler N.K., Roth A.M., Management and monitoring of cancer associated retinopathy, Arch Ophthalmol, 110, (1992)
[5]  
Thirkill C.E., Roth A.M., Keltner J.L., Cancer-associated retinopathy. Arch Ophthalmol, 105, (1987)
[6]  
Adamus G., Guy J., Schmied J.L., Arendt A., Hargrave P., Role of anti-recoverin autoantibodies in cancer-associated retinopathy, Invest Ophthalmol Vis SCi, 34, (1993)
[7]  
Grunwald G.B., Komguth S.E., Towfighi J., Sassani J., Simmonds M.A., Housman C.M., Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells, Cancer, 60, (1987)
[8]  
Polans A.S., Buczylko J., Crabb J., Palczewski K., A photoreceptor calcium binding protein is recognized by autoantibodies obtained from retinopathy, J Cell Biol, 112, (1991)
[9]  
Polans A.S., Burton M.D., Haley T.L., Crabb J.W., Palczewski K., Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy, Invest Ophthalmol Vis Sci, 34, (1993)
[10]  
Thirkill C.E., Fitzgerald P., Sergott R.C., Roth A.M., Tyler N.K., Keltner J.L., Cancer associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic nerve, and cancer cells, N Engl3JMed, 321, (1989)